alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Term ID

CHEBI:142933

Synonyms

alpha-L-Fuc-(1->2)-(alpha-D-GalNAc-(1->3))-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-[alpha-L-Fuc-(1->2)-(alpha-D-GalNAc-(1->3))-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1(4E
alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-bet
lacto IV(3)-(a-Fuc1-2-(a-GalNAc1-3)-b-Gal1-3-b-GlcNAc),IV(6)-(a-Fuc1-2-(a-GalNAc1-3)-b-Gal1-3-b-GlcNAc)-Lc4Cer(d18:1(4E))

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide organic molecular entity

alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide organic molecular entity Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Phenotype where environments contain alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Phenotype modified by environments containing alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))

Human Disease Model